TSX News -
Onex to Announce Third Quarter 2024 Results on November 8, 2024
All amounts in U.S. dollars unless otherwise stated TORONTO, Oct. 22, 2024 (GLOBE NEWSWIRE) — Onex Corporation (TSX: ONEX) will […]
Sportradar Deepens Official Partnership with NBA with Launch of Innovative, Value-Add Fan Engagement Solutions
NEW YORK and ST. GALLEN, Switzerland, Oct. 22, 2024 (GLOBE NEWSWIRE) — Sportradar (NASDAQ: SRAD) is enhancing its partnership with […]
AgriFORCE to Present at the LD Micro Main Event XVII
VANCOUVER, British Columbia, Oct. 22, 2024 (GLOBE NEWSWIRE) — AgriFORCE Growing Systems Ltd. (the “Company”) (NASDAQ: AGRI), an intellectual property […]
Alvarez & Marsal selects Intapp to strengthen deal management
PALO ALTO, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) — Intapp (NASDAQ: INTA), a leading global provider of AI-powered solutions for […]
Warner Music Group Corp. to Conduct Earnings Conference Call on Thursday, November 21, 2024
NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) — Warner Music Group Corp. will release its financial results on Thursday, November […]
GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE
Continuous blood glucose monitor to be among 100+ future-focused presentations at industry investor conference Rutherford, NJ, Oct. 22, 2024 (GLOBE […]
Fazoli’s Serves Up Free Breadsticks for National Breadstick Day
Italian Chain Rolls Out Three-Day Celebration for Beloved Baked Menu Item LOS ANGELES, Oct. 22, 2024 (GLOBE NEWSWIRE) — Fazoli’s, […]
SAGA Metals Announces Assay Results from Radar Titanium-Vanadium Project
Key Assay Highlights: Total Samples Analyzed: 388 rock samples. Titanium Dioxide (TiO2): 49 samples returned assay values over 4.0% TiO2, […]
Stifel Receives Final Approval for Private Equity Fund Aimed at Investing in National Security Supply Chain
ST. LOUIS, Oct. 22, 2024 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today announced final federal approval for its […]
Kairos Pharma to Present at the LD Micro Main Event XVII
LOS ANGELES, Oct. 22, 2024 (GLOBE NEWSWIRE) — Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announced today […]
